Literature DB >> 8923461

Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4.

Y Zhao1, J E Nichols, R Valdez, C R Mendelson, E R Simpson.   

Abstract

Expression of aromatase P450 (P450arom; the product of the CYP19 gene) in human adipose stromal cells in primary culture is markedly stimulated by serum in the presence of dexamethasone (DEX). Under these conditions, the majority of P450arom transcripts contain untranslated exon 1.4 at their 5'-ends. Previously, we observed that the region of the CYP19 gene upstream of exon 1.4 contains a TATA-less promoter, a glucocorticoid response element, and an interferon-gamma-activating sequence. These act to mediate the action of interleukin-6 and related cytokines to stimulate aromatase expression in the presence of DEX. In the present study, we found that tumor necrosis factor-alpha (TNF alpha) also acts synergistically with DEX to stimulate aromatase expression in adipose stromal cells in serum-free medium. We observed that the action of TNF alpha can be mimicked by ceramide. Maximal aromatase activity was obtained when cells were incubated with 5 ng/ml TNF alpha or 100 nM ceramide in the presence of 250 nM DEX. Levels of c-fos and c-jun proteins also were increased by TNF alpha or ceramide in the presence of DEX. Upstream of the interferon-gamma-activating sequence site there is an imperfect activating protein-1 (AP-1) binding site (2-bp mismatch). Gel retardation analysis using nucleotide probes containing the putative AP-1-binding sequence and nuclear extracts of human adipose stromal cells cultured in the presence of TNF alpha or ceramide plus DEX revealed that adipose stromal cells nuclear proteins bind to this site and that binding was competed by a 100-fold excess of a consensus AP-1 sequence. In addition, binding activity was competed by both anti-c-fos and anti-c-jun sera. Mutation or deletion of the putative AP-1 element resulted in the loss of TNF alpha- plus DEX-induced activity of reporter constructs comprised of 515 bp of the exon 1.4 flanking sequence linked to the luciferase gene. These results suggest that TNF alpha, probably acting through ceramide formation, stimulates the binding of both c-fos and c-jun to the AP-1 element upstream of exon 1.4. These act cooperatively with the ligand-activated glucocorticoid receptor to induce aromatase expression in adipose stromal cells in primary culture. We conclude that this TNF alpha signal transduction pathway may play an important role in the regulation of estrogen biosynthesis in adipose tissue.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8923461     DOI: 10.1210/mend.10.11.8923461

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  54 in total

Review 1.  Enzymatic intracrine regulation of white adipose tissue.

Authors:  David DiSilvestro; Jennifer Petrosino; Ayat Aldoori; Emiliano Melgar-Bermudez; Alexandra Wells; Ouliana Ziouzenkova
Journal:  Horm Mol Biol Clin Investig       Date:  2014-07

Review 2.  Aromatase, breast cancer and obesity: a complex interaction.

Authors:  Serdar E Bulun; Dong Chen; Irene Moy; David C Brooks; Hong Zhao
Journal:  Trends Endocrinol Metab       Date:  2011-12-12       Impact factor: 12.015

Review 3.  Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers.

Authors:  Sarah C Baumgarten; Jonna Frasor
Journal:  Mol Endocrinol       Date:  2012-02-02

4.  Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility.

Authors:  Michelle R Jones; Gregorio Chazenbalk; Ning Xu; Angela K Chua; Tamar Eigler; Emebet Mengesha; Yen-Hao Chen; Jung-Min Lee; Marita Pall; Xiaohui Li; Yii-Der I Chen; Kent D Taylor; Ruchi Mathur; Ronald M Krauss; Jerome I Rotter; Richard S Legro; Ricardo Azziz; Mark O Goodarzi
Journal:  J Clin Endocrinol Metab       Date:  2012-06-21       Impact factor: 5.958

5.  Sexual dimorphism in SARS-COV-2 infection.

Authors:  Z S Ulhaq; G V Soraya; L E A Zambrano; C P Garcia
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Oct-Dec       Impact factor: 0.877

Review 6.  The obesity-inflammation-eicosanoid axis in breast cancer.

Authors:  Linda Vona-Davis; David P Rose
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-10-30       Impact factor: 2.673

Review 7.  Obesity and cancer--mechanisms underlying tumour progression and recurrence.

Authors:  Jiyoung Park; Thomas S Morley; Min Kim; Deborah J Clegg; Philipp E Scherer
Journal:  Nat Rev Endocrinol       Date:  2014-06-17       Impact factor: 43.330

Review 8.  Impact of obesity on mammary gland inflammation and local estrogen production.

Authors:  Kristy A Brown
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-06-17       Impact factor: 2.673

9.  Estradiol and metabolic syndrome in older italian men: The InCHIANTI Study.

Authors:  Marcello Maggio; Fulvio Lauretani; Gian Paolo Ceda; Stefania Bandinelli; Shehzad Basaria; Giuseppe Paolisso; Claudio Giumelli; Michele Luci; Samer S Najjar; E Jeffrey Metter; Giorgio Valenti; Jack Guralnik; Luigi Ferrucci
Journal:  J Androl       Date:  2008-12-04

Review 10.  Biology of aromatase in the mammary gland.

Authors:  E R Simpson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-07       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.